Blockbuster Oncology Brands Market Size, Share & Trends Report

Blockbuster Oncology Brands Market Size, Share & Trends Analysis Report By Brand (Opdivo, Revlimid, Zejula), By Indication (Lung Cancer, Lymphoma, Multiple Myeloma), And Segment Forecasts, 2018 - 2027

Report ID: GVR-2-68038-603-5
Number of Pages: 170
Format: Electronic (PDF)

Historical Range: 2015 - 2016
Industry: Healthcare

Market Segmentation

Blockbuster Oncology Brands Outlook (Revenue, USD Million, 2015 - 2027)
- Opdivo
- Keytruda
- Perjeta
- Ibrance
- Tecentriq
- Gazyva
- Tagrisso
- Darzalex
- Zejula
- Revlimid
- Imbruvica
Blockbuster Oncology Brands Indication Outlook (Revenue, USD Million, 2015 - 2027)
- Lung cancer
- Breast cancer
- Multiple myeloma
- Lymphoma
- Others
Blockbuster Oncology Brands Regional Outlook (Revenue, USD Million, 2015 - 2027)
- North America
  - North America Blockbuster Oncology Brands Market, by Brands
    - Opdivo
    - Keytruda
    - Perjeta
    - Ibrance
    - Tecentriq
    - Gazyva
    - Tagrisso
    - Darzalex
    - Zejula
    - Revlimid
    - Imbruvica
  - North America Blockbuster Oncology Brands Market, by Indication
    - Lung cancer
    - Breast cancer
    - Multiple myeloma
    - Lymphoma
    - Others
  - The U.S.
    - The U.S. Blockbuster Oncology Brands Market, by Brands
      - Opdivo
      - Keytruda
      - Perjeta
      - Ibrance
      - Tecentriq
      - Gazyva
      - Tagrisso
      - Darzalex
      - Zejula
      - Revlimid
      - Imbruvica
    - The U.S. Blockbuster Oncology Brands Market, by Indication
      - Lung cancer
      - Breast cancer
      - Multiple myeloma
      - Lymphoma
      - Others
  - Canada
    - Canada Blockbuster Oncology Brands Market, by Brands
      - Opdivo
      - Keytruda
      - Perjeta
      - Ibrance
      - Tecentriq
      - Gazyva
      - Tagrisso
      - Darzalex
      - Zejula
      - Revlimid
      - Imbruvica
    - Canada Blockbuster Oncology Brands Market, by Indication
      - Lung cancer
      - Breast cancer
      - Multiple myeloma
      - Lymphoma
      - Others
- Europe
  - Europe Blockbuster Oncology Brands Market, by Brands
    - Opdivo
    - Keytruda
    - Perjeta
    - Ibrance
    - Tecentriq
    - Gazyva
    - Tagrisso
    - Darzalex
    - Zejula
    - Revlimid
    - Imbruvica
  - Europe Blockbuster Oncology Brands Market, by Indication
    - Lung cancer
    - Breast cancer
    - Multiple myeloma
    - Lymphoma
    - Others
  - The U.K.
    - The U.K. Blockbuster Oncology Brands Market, by Brands
      - Opdivo
      - Keytruda
      - Perjeta
      - Ibrance
      - Tecentriq
      - Gazyva
      - Tagrisso
      - Darzalex
      - Zejula
      - Revlimid
      - Imbruvica
    - The U.K. Blockbuster Oncology Brands Market, by Indication
      - Lung cancer
      - Breast cancer
      - Multiple myeloma
      - Lymphoma
      - Others
  - Germany
    - Germany Blockbuster Oncology Brands Market, by Brands
      - Opdivo
      - Keytruda
      - Perjeta
      - Ibrance
      - Tecentriq
      - Gazyva
      - Tagrisso
      - Darzalex
      - Zejula
      - Revlimid
      - Imbruvica
    - Germany Blockbuster Oncology Brands Market, by Indication
      - Lung cancer
      - Breast cancer
      - Multiple myeloma
      - Lymphoma
      - Others
  - Italy
    - Italy Blockbuster Oncology Brands Market, by Brands
      - Opdivo
      - Keytruda
      - Perjeta
      - Ibrance
      - Tecentriq
      - Gazyva
      - Tagrisso
      - Darzalex
      - Zejula
      - Revlimid
      - Imbruvica
    - Italy Blockbuster Oncology Brands Market, by Indication
      - Lung cancer
      - Breast cancer
      - Multiple myeloma
      - Lymphoma
      - Others
  - Switzerland
    - Switzerland Blockbuster Oncology Brands Market, by Brands
      - Opdivo
      - Keytruda
      - Perjeta
      - Ibrance
      - Tecentriq
      - Gazyva
      - Tagrisso
      - Darzalex
      - Zejula
      - Revlimid
      - Imbruvica
    - Switzerland Blockbuster Oncology Brands Market, by Indication
      - Lung cancer
      - Breast cancer
      - Multiple myeloma
      - Lymphoma
      - Others
  - France
    - France Blockbuster Oncology Brands Market, by Brands
      - Opdivo
      - Keytruda
      - Perjeta
      - Ibrance
      - Tecentriq
      - Gazyva
      - Tagrisso
      - Darzalex
      - Zejula
      - Revlimid
      - Imbruvica
    - France Blockbuster Oncology Brands Market, by Indication
      - Lung cancer
      - Breast cancer
      - Multiple myeloma
      - Lymphoma
      - Others
  - Spain
    - Spain Blockbuster Oncology Brands Market, by Brands
      - Opdivo
      - Keytruda
      - Perjeta
      - Ibrance
      - Tecentriq
      - Gazyva
      - Tagrisso
      - Darzalex
      - Zejula
      - Revlimid
      - Imbruvica
    - Spain Blockbuster Oncology Brands Market, by Indication
      - Lung cancer
      - Breast cancer
      - Multiple myeloma
      - Lymphoma
      - Others
  - Poland
    - Poland Blockbuster Oncology Brands Market, by Brands
      - Opdivo
      - Keytruda
      - Perjeta
      - Ibrance
      - Tecentriq
      - Gazyva
      - Tagrisso
      - Darzalex
      - Zejula
      - Revlimid
      - Imbruvica
    - Poland Blockbuster Oncology Brands Market, by Indication
      - Lung cancer
      - Breast cancer
      - Multiple myeloma
      - Lymphoma
      - Others
  - Denmark
    - Denmark Blockbuster Oncology Brands Market, by Brands
      - Opdivo
      - Keytruda
      - Perjeta
      - Ibrance
      - Tecentriq
      - Gazyva
      - Tagrisso
      - Darzalex
      - Zejula
      - Revlimid
      - Imbruvica
    - Denmark Blockbuster Oncology Brands Market, by Indication
      - Lung cancer
      - Breast cancer
      - Multiple myeloma
      - Lymphoma
      - Others
- Asia Pacific
  - Asia Pacific Blockbuster Oncology Brands Market, by Brands
    - Opdivo
    - Keytruda
    - Perjeta
    - Ibrance
    - Tecentriq
    - Gazyva
    - Tagrisso
    - Darzalex
    - Zejula
    - Revlimid
    - Imbruvica
  - Asia Pacific Blockbuster Oncology Brands Market, by Indication
    - Lung cancer
    - Breast cancer
    - Multiple myeloma
    - Lymphoma
    - Others
  - Japan
    - Japan Blockbuster Oncology Brands Market, by Brands
      - Opdivo
      - Keytruda
      - Perjeta
      - Ibrance
      - Tecentriq
      - Gazyva
      - Tagrisso
      - Darzalex
      - Zejula
      - Revlimid
      - Imbruvica
    - Japan Blockbuster Oncology Brands Market, by Indication
      - Lung cancer
      - Breast cancer
      - Multiple myeloma
      - Lymphoma
      - Others
  - China
    - China Blockbuster Oncology Brands Market, by Brands
      - Opdivo
      - Keytruda
      - Perjeta
      - Ibrance
      - Tecentriq
      - Gazyva
      - Tagrisso
      - Darzalex
      - Zejula
      - Revlimid
      - Imbruvica
    - China Blockbuster Oncology Brands Market, by Indication
      - Lung cancer
      - Breast cancer
      - Multiple myeloma
      - Lymphoma
      - Others
  - India
    - India Blockbuster Oncology Brands Market, by Brands
      - Opdivo
      - Keytruda
      - Perjeta
      - Ibrance
      - Tecentriq
      - Gazyva
      - Tagrisso
      - Darzalex
      - Zejula
      - Revlimid
      - Imbruvica
    - India Blockbuster Oncology Brands Market, by Indication
      - Lung cancer
      - Breast cancer
      - Multiple myeloma
      - Lymphoma
      - Others
  - Australia
    - Australia Blockbuster Oncology Brands Market, by Brands
      - Opdivo
      - Keytruda
      - Perjeta
      - Ibrance
      - Tecentriq
      - Gazyva
      - Tagrisso
      - Darzalex
      - Zejula
      - Revlimid
      - Imbruvica
    - Australia Blockbuster Oncology Brands Market, by Indication
      - Lung cancer
      - Breast cancer
      - Multiple myeloma
      - Lymphoma
      - Others
  - New Zealand
    - New Zealand Blockbuster Oncology Brands Market, by Brands
      - Opdivo
      - Keytruda
      - Perjeta
      - Ibrance
      - Tecentriq
      - Gazyva
      - Tagrisso
      - Darzalex
      - Zejula
      - Revlimid
      - Imbruvica
    - New Zealand Blockbuster Oncology Brands Market, by Indication
      - Lung cancer
      - Breast cancer
      - Multiple myeloma
      - Lymphoma
      - Others
  - Hong Kong
    - Hong Kong Blockbuster Oncology Brands Market, by Brands
      - Opdivo
      - Keytruda
      - Perjeta
      - Ibrance
      - Tecentriq
      - Gazyva
      - Tagrisso
      - Darzalex
      - Zejula
      - Revlimid
      - Imbruvica
    - Hong Kong Blockbuster Oncology Brands Market, by Indication
      - Lung cancer
      - Breast cancer
      - Multiple myeloma
      - Lymphoma
      - Others
  - Singapore
    - Singapore Blockbuster Oncology Brands Market, by Brands
      - Opdivo
      - Keytruda
      - Perjeta
      - Ibrance
      - Tecentriq
      - Gazyva
      - Tagrisso
      - Darzalex
      - Zejula
      - Revlimid
      - Imbruvica
    - Singapore Blockbuster Oncology Brands Market, by Indication
      - Lung cancer
      - Breast cancer
      - Multiple myeloma
      - Lymphoma
      - Others
  - Philippines
    - Philippines Blockbuster Oncology Brands Market, by Brands
      - Opdivo
      - Keytruda
      - Perjeta
      - Ibrance
      - Tecentriq
      - Gazyva
      - Tagrisso
      - Darzalex
      - Zejula
      - Revlimid
      - Imbruvica
    - Philippines Blockbuster Oncology Brands Market, by Indication
      - Lung cancer
      - Breast cancer
      - Multiple myeloma
      - Lymphoma
      - Others
  - South Korea
    - South Korea Blockbuster Oncology Brands Market, by Brands
      - Opdivo
      - Keytruda
      - Perjeta
      - Ibrance
      - Tecentriq
      - Gazyva
      - Tagrisso
      - Darzalex
      - Zejula
      - Revlimid
      - Imbruvica
    - South Korea Blockbuster Oncology Brands Market, by Indication
      - Lung cancer
      - Breast cancer
      - Multiple myeloma
      - Lymphoma
      - Others
  - Indonesia
    - Indonesia Blockbuster Oncology Brands Market, by Brands
      - Opdivo
      - Keytruda
      - Perjeta
      - Ibrance
      - Tecentriq
      - Gazyva
      - Tagrisso
      - Darzalex
      - Zejula
      - Revlimid
      - Imbruvica
    - Indonesia Blockbuster Oncology Brands Market, by Indication
      - Lung cancer
      - Breast cancer
      - Multiple myeloma
      - Lymphoma
      - Others
- Latin America
  - Latin America Blockbuster Oncology Brands Market, by Brands
    - Opdivo
    - Keytruda
    - Perjeta
    - Ibrance
    - Tecentriq
    - Gazyva
    - Tagrisso
    - Darzalex
    - Zejula
    - Revlimid
    - Imbruvica
  - Latin America Blockbuster Oncology Brands Market, by Indication
    - Lung cancer
    - Breast cancer
    - Multiple myeloma
    - Lymphoma
    - Others
  - Brazil
    - Brazil Blockbuster Oncology Brands Market, by Brands
      - Opdivo
      - Keytruda
      - Perjeta
      - Ibrance
      - Tecentriq
      - Gazyva
      - Tagrisso
      - Darzalex
      - Zejula
      - Revlimid
      - Imbruvica
    - Brazil Blockbuster Oncology Brands Market, by Indication
      - Lung cancer
      - Breast cancer
      - Multiple myeloma
      - Lymphoma
      - Others
  - Mexico
    - Mexico Blockbuster Oncology Brands Market, by Brands
      - Opdivo
      - Keytruda
      - Perjeta
      - Ibrance
      - Tecentriq
      - Gazyva
      - Tagrisso
      - Darzalex
      - Zejula
      - Revlimid
      - Imbruvica
    - Mexico Blockbuster Oncology Brands Market, by Indication
      - Lung cancer
      - Breast cancer
      - Multiple myeloma
      - Lymphoma
      - Others
  - Argentina
    - Argentina Blockbuster Oncology Brands Market, by Brands
      - Opdivo
      - Keytruda
      - Perjeta
      - Ibrance
      - Tecentriq
      - Gazyva
      - Tagrisso
      - Darzalex
      - Zejula
      - Revlimid
      - Imbruvica
    - Argentina Blockbuster Oncology Brands Market, by Indication
      - Lung cancer
      - Breast cancer
      - Multiple myeloma
      - Lymphoma
      - Others
- The Middle East & Africa
  - The Middle East & Africa Blockbuster Oncology Brands Market, by Brands
    - Opdivo
    - Keytruda
    - Perjeta
    - Ibrance
    - Tecentriq
    - Gazyva
    - Tagrisso
    - Darzalex
    - Zejula
    - Revlimid
    - Imbruvica
  - The Middle East & Africa Blockbuster Oncology Brands Market, by Indication
    - Lung cancer
    - Breast cancer
    - Multiple myeloma
    - Lymphoma
    - Others
  - Israel
    - Israel Blockbuster Oncology Brands Market, by Brands
      - Opdivo
      - Keytruda
      - Perjeta
      - Ibrance
      - Tecentriq
      - Gazyva
      - Tagrisso
      - Darzalex
      - Zejula
      - Revlimid
      - Imbruvica
    - Israel Blockbuster Oncology Brands Market, by Indication
      - Lung cancer
      - Breast cancer
      - Multiple myeloma
      - Lymphoma
      - Others
  - Turkey
    - Turkey Blockbuster Oncology Brands Market, by Brands
      - Opdivo
      - Keytruda
      - Perjeta
      - Ibrance
      - Tecentriq
      - Gazyva
      - Tagrisso
      - Darzalex
      - Zejula
      - Revlimid
      - Imbruvica
    - Turkey Blockbuster Oncology Brands Market, by Indication
      - Lung cancer
      - Breast cancer
      - Multiple myeloma
      - Lymphoma
      - Others
  - Saudi Arabia
    - Saudi Arabia Blockbuster Oncology Brands Market, by Brands
      - Opdivo
      - Keytruda
      - Perjeta
      - Ibrance
      - Tecentriq
      - Gazyva
      - Tagrisso
      - Darzalex
      - Zejula
      - Revlimid
      - Imbruvica
    - Saudi Arabia Blockbuster Oncology Brands Market, by Indication
      - Lung cancer
      - Breast cancer
      - Multiple myeloma
      - Lymphoma
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2015 to 2027
Market estimates and forecast for product segments up to 2027
Regional market size and forecast for product segments up to 2027
Market estimates and forecast for application segments up to 2027
Regional market size and forecast for application segments up to 2027
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.